Pharmacokinetics and biodistribution of 111In- and 177Lu-labeled J591 antibody specific for prostate-specific membrane antigen: prediction of 90Y-J591 radiation dosimetry based on 111In or 177Lu? [electronic resource]
Producer: 20050607Description: 634-41 p. digitalISSN:- 0161-5505
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal -- pharmacokinetics
- Body Burden
- Half-Life
- Humans
- Indium Radioisotopes -- pharmacokinetics
- Lutetium -- pharmacokinetics
- Male
- Metabolic Clearance Rate
- Middle Aged
- Organ Specificity
- Prostate-Specific Antigen -- immunology
- Prostatic Neoplasms -- metabolism
- Radioisotopes -- pharmacokinetics
- Radiometry -- methods
- Radiopharmaceuticals -- pharmacokinetics
- Radiotherapy Dosage
- Relative Biological Effectiveness
- Tissue Distribution
- Yttrium Radioisotopes -- pharmacokinetics
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.